"Precision Medicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.
| Descriptor ID |
D057285
|
| MeSH Number(s) |
E02.574 H02.403.200.700
|
| Concept/Terms |
Precision Medicine- Precision Medicine
- Medicine, Precision
- Personalized Medicine
- Medicine, Personalized
- Individualized Medicine
- Medicine, Individualized
|
Below are MeSH descriptors whose meaning is more general than "Precision Medicine".
Below are MeSH descriptors whose meaning is more specific than "Precision Medicine".
This graph shows the total number of publications written about "Precision Medicine" by people in this website by year, and whether "Precision Medicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 1 | 2 |
| 2010 | 8 | 0 | 8 |
| 2011 | 12 | 3 | 15 |
| 2012 | 5 | 4 | 9 |
| 2013 | 5 | 8 | 13 |
| 2014 | 6 | 5 | 11 |
| 2015 | 16 | 4 | 20 |
| 2016 | 11 | 9 | 20 |
| 2017 | 10 | 13 | 23 |
| 2018 | 15 | 10 | 25 |
| 2019 | 16 | 21 | 37 |
| 2020 | 18 | 12 | 30 |
| 2021 | 15 | 14 | 29 |
| 2022 | 4 | 11 | 15 |
| 2023 | 3 | 11 | 14 |
| 2024 | 8 | 8 | 16 |
| 2025 | 11 | 10 | 21 |
| 2026 | 12 | 8 | 20 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precision Medicine" by people in Profiles.
-
Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncol. 2026 Oct; 27(10):e454-e507.
-
Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic. Expert Opin Drug Deliv. 2026 Oct; 23(10):1761-1774.
-
A complete diploid human genome benchmark for personalized genomics. Cell. 2026 Aug 06; 189(16):4857-4875.e31.
-
Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed. Science. 2026 Jul 16; 393(6808):eadx2989.
-
The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided care. Cell Rep Med. 2026 Jun 16; 7(6):102790.
-
Data-driven personalized surgical treatment selection for metopic and sagittal craniosynostosis. J Neurosurg Pediatr. 2026 May 29; 38(2):195-204.
-
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL. Blood Cancer Discov. 2026 05 05; 7(3):369-379.
-
Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses. Cancer Metastasis Rev. 2026 05 01; 45(2).
-
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520666.
-
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520834.